Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Guy F Webster, James J Leyden, Jason A Gross
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2337798743